Z-1109-2021 Class II Terminated
FDA device recall Z-1109-2021 was initiated by Becton Dickinson & Company on Dec 23, 2020 and is designated Class II. Reason for recall: The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe. The recall status is terminated (terminated Nov 21, 2022). Affected quantity: 155,200 needles.
Recall details
- Product Type
- Devices
- Report Date
- Feb 24, 2021
- Initiation Date
- Dec 23, 2020
- Termination Date
- Nov 21, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 155,200 needles
Product description
BD Hypodermic Syringe 10 ml, eccentric tip. Catalog (Ref No.) 305482
Reason for recall
The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe.
Distribution pattern
Distribution US nationwide and Canada
Code information
Catalog (Ref No.) 305482 100/package UDI 00382903054824 Lot # 8142303 exp date 31-May-2023
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1109-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026